Cargando…
NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534097/ https://www.ncbi.nlm.nih.gov/pubmed/34685559 http://dx.doi.org/10.3390/cells10102577 |
_version_ | 1784587473022615552 |
---|---|
author | Wright, Imogen A. Delaney, Kayla E. Katusiime, Mary Grace K. Botha, Johannes C. Engelbrecht, Susan Kearney, Mary F. van Zyl, Gert U. |
author_facet | Wright, Imogen A. Delaney, Kayla E. Katusiime, Mary Grace K. Botha, Johannes C. Engelbrecht, Susan Kearney, Mary F. van Zyl, Gert U. |
author_sort | Wright, Imogen A. |
collection | PubMed |
description | HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the barrier to an HIV cure. Oxford Nanopore Technologies (ONT) sequencing offers a promising, cost-effective approach to the sequencing of long amplicons such as near full-length HIV-1 proviruses, but the high diversity of HIV-1 and the ONT sequencing error render analysis of the generated data difficult. NanoHIV is a new tool that uses an iterative consensus generation approach to construct accurate, near full-length HIV-1 proviral single-genome sequences from ONT data. To validate the approach, single-genome sequences generated using NanoHIV consensus building were compared to Illumina(®) consensus building of the same nine single-genome near full-length amplicons and an average agreement of 99.4% was found between the two sequencing approaches. |
format | Online Article Text |
id | pubmed-8534097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85340972021-10-23 NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology Wright, Imogen A. Delaney, Kayla E. Katusiime, Mary Grace K. Botha, Johannes C. Engelbrecht, Susan Kearney, Mary F. van Zyl, Gert U. Cells Article HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the barrier to an HIV cure. Oxford Nanopore Technologies (ONT) sequencing offers a promising, cost-effective approach to the sequencing of long amplicons such as near full-length HIV-1 proviruses, but the high diversity of HIV-1 and the ONT sequencing error render analysis of the generated data difficult. NanoHIV is a new tool that uses an iterative consensus generation approach to construct accurate, near full-length HIV-1 proviral single-genome sequences from ONT data. To validate the approach, single-genome sequences generated using NanoHIV consensus building were compared to Illumina(®) consensus building of the same nine single-genome near full-length amplicons and an average agreement of 99.4% was found between the two sequencing approaches. MDPI 2021-09-28 /pmc/articles/PMC8534097/ /pubmed/34685559 http://dx.doi.org/10.3390/cells10102577 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wright, Imogen A. Delaney, Kayla E. Katusiime, Mary Grace K. Botha, Johannes C. Engelbrecht, Susan Kearney, Mary F. van Zyl, Gert U. NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title | NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title_full | NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title_fullStr | NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title_full_unstemmed | NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title_short | NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology |
title_sort | nanohiv: a bioinformatics pipeline for producing accurate, near full-length hiv proviral genomes sequenced using the oxford nanopore technology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534097/ https://www.ncbi.nlm.nih.gov/pubmed/34685559 http://dx.doi.org/10.3390/cells10102577 |
work_keys_str_mv | AT wrightimogena nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT delaneykaylae nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT katusiimemarygracek nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT bothajohannesc nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT engelbrechtsusan nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT kearneymaryf nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology AT vanzylgertu nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology |